ID   ZEC-219
AC   CVCL_VT89
DR   CCRID; 4201PAT-CCTCC00889
DR   Wikidata; Q98136476
RX   Patent=CN106047816A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201688.
CC   Population: Chinese.
CC   Doubling time: ~53 hours (Patent=CN106047816A).
ST   Source(s): Patent=CN106047816A
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20
ST   D13S317: 12
ST   D16S539: 10,13
ST   D18S51: 13
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 23
ST   D3S1358: 17
ST   D5S818: 11
ST   D6S1043: 11,18
ST   D7S820: 11,12
ST   D8S1179: 15,16
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 16,19
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 18,21
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 8
//
RX   Patent=CN106047816A;
RA   Su D., Mao W.-M., Chen P.-C., Ying L.-S., Wu J.-Z.;
RT   "Esophageal cancer cell line and application thereof.";
RL   Patent number CN106047816A, 26-Oct-2016.
//